|
Mar 17
|
Johnson & Johnson (JNJ) Rises But Trails Market: What Investors Should Know
|
|
Mar 17
|
How to Boost Your Portfolio with Top Medical Stocks Set to Beat Earnings
|
|
Mar 17
|
The S&P 500 Is in Correction Territory: 4 Surefire Stocks to Buy Right Now
|
|
Mar 14
|
Hostage to Legal Decisions – Here’s Why Jim Cramer Gave Up on Johnson & Johnson (JNJ)
|
|
Mar 14
|
Zimmer Biomet Focuses on Innovation Amid Growing Competition
|
|
Mar 14
|
Big Pharma Walked Away From Mental Health. Why Some Are Coming Back.
|
|
Mar 14
|
Q4 Earnings Recap: Supernus Pharmaceuticals (NASDAQ:SUPN) Tops Branded Pharmaceuticals Stocks
|
|
Mar 14
|
Johnson & Johnson (JNJ): “Breakout or Breakdown?” – Jim Cramer Says JNJ Must Fall for Market to Bottom
|
|
Mar 13
|
Johnson & Johnson (NYSE:JNJ) Faces Shareholder Activism Over Human Rights and Executive Pay Proposals
|
|
Mar 13
|
FDA grants 510(k) clearance for J&J MedTech’s Monarch Quest
|
|
Mar 13
|
J&J’s Monarch robot wins FDA nod for AI software update
|
|
Mar 12
|
Why Johnson & Johnson (JNJ) is the Best Pharma Stock to Buy According to Hedge Funds
|
|
Mar 12
|
Johnson & Johnson (JNJ): Among Dobermans of the Dow to Buy
|
|
Mar 12
|
Johnson & Johnson (JNJ) is Attracting Investor Attention: Here is What You Should Know
|
|
Mar 11
|
Johnson & Johnson (NYSE:JNJ) Reports Positive Phase 2b Trial Results For Ulcerative Colitis Treatment
|
|
Mar 11
|
PTGX Up as J&J-Partnered Drug Meets Goal in Ulcerative Colitis Study
|
|
Mar 11
|
Is Johnson & Johnson (JNJ) the Best Low Risk Stock to Buy In 2025?
|
|
Mar 11
|
Genmab says J&J not exercising option on HexaBody-CD38
|
|
Mar 11
|
Protagonist Therapeutics Soars as Icotrokinra Drives Breakthrough Success
|
|
Mar 11
|
J&J and Protagonist’s icotrokinra scores in Phase IIb UC study
|